DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Rash - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Rash (142)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include rash. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 142   Next >>

Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-07

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-30

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-06-24

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-08

Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Start date: 2012-06-19

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-19

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-03

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Start date: 2012-06-19



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-25

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-02

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-07-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Fatigue, Pruritus, Rash, Drug Abuse, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05



Possible Rebetol side effects in 39 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 39 year old female

Reactions: Anaemia, Rash, Neutrophil Count Decreased

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-07-05

Peginterferon Alfa-2B
    Dosage: 1.1 a?g/kg, unk
    Start date: 2012-07-20
    End date: 2012-07-26

Peginterferon Alfa-2B
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-07-27
    End date: 2012-08-02

Peginterferon Alfa-2B
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-07-06
    End date: 2012-07-19

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-25
    End date: 2012-08-02

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-03-22

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-05-10



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.4 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-30
    End date: 2012-07-04

Prednisolone
    Dosage: 50 mg, qd, formulation : por
    Administration route: Oral
    Start date: 2012-07-10

Prednisolone
    Dosage: 20 mg, qd, formulation : por
    Administration route: Oral
    Start date: 2012-07-02

Prednisolone
    Dosage: 10 mg, qd, formulation : por
    Administration route: Oral
    Start date: 2012-07-04

Prednisolone
    Dosage: 20 mg, qd, formulation : por
    Administration route: Oral
    Start date: 2012-07-06

Prednisolone
    Dosage: 60 mg, qd, formulation : por
    Administration route: Oral
    Start date: 2012-07-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-30
    End date: 2012-06-12

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-07-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-30
    End date: 2012-07-07

Other drugs received by patient: Alendronate Sodium; Acetaminophen; Clobetasol Propionate; Kindavate; Levofloxacin; Allegra; Famotidine; Rabeprazole Sodium; Azunol (Sodium Gualenate)



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30



Possible Rebetol side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 51 year old male

Reactions: Retinal Haemorrhage, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-12

PEG-Intron
    Dosage: 1 a?g/kg, unk
    Start date: 2012-05-17
    End date: 2012-07-05

PEG-Intron
    Dosage: 0.75 a?g/kg, unk
    Start date: 2012-04-13
    End date: 2012-05-10

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-02-15

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-23
    End date: 2012-03-14

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-15
    End date: 2012-05-23

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-16
    End date: 2012-02-22

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-07-11

Ursodiol
    Dosage: 900 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-10-05
    End date: 2012-03-07

Ursodiol
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-03-28

Ursodiol
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-04-05

Other drugs received by patient: Youcobal / 00091803 /; Depas; Omeprazole; Calblock; Candesartan Cilexetil; Hyalein; Allopurinol; Halcion; Candesartan Cilexetil; Allopurinol; BIO-Three; Flomox; Rabeprazole Sodium; Rohypnol; Lendormin; Polaramine; Neophagen C; Livostin; Adenosine



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Pruritus, Anaemia, Chest Pain, DRY Skin, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram/0.5 ml, qw

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral

Other drugs received by patient: Vitamins (Unspecified); Cyanocobalamin; Tylenol; Telaprevir



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Disorder, Rash, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-05-15

Antiviral (Unspecified)
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-18

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-17

Antiviral (Unspecified)
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-06

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-04-14

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Rebetol
    Dosage: 200mg/every other day
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-06-12

Rebetol
    Administration route: Oral
    Start date: 2012-06-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

Telavic
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

Telavic
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-06-01

Telavic
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-17

Telavic
    Administration route: Oral
    Start date: 2012-06-02
    End date: 2012-06-29

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Telavic
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-05-15

Other drugs received by patient: Nexium; Gaslon N; Allegra; Coniel; Potassium Chloride; Nexium; Gaslon N; Amaryl; Telmisartan; Dextrose (+) Electrolytes (Unspecified) (+) Sodium Lactate; Amaryl; Hirudoid; Telmisartan; Coniel; Coniel



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Oedema, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01

Other drugs received by patient: Polaramine; Oxatomide; Lansoprazole; Ibruprofen



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-06-13

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-06-13

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-06-13



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Gallbladder Pain, Glossodynia, Dyspnoea, Rash, Eructation, Dysgeusia, Irritability, Fatigue, Vision Blurred, Parosmia, Cholecystitis, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 micrograms/0.5 milliliters

Rebetol
    Dosage: unk mg, unk

Victrelis
    Dosage: unk mg, unk

Other drugs received by patient: Doxycycline HCL; Lisinopril; Neurontin; Oxycodone HCL; Omeprazole; Viibryd



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Rash, Neutrophil Count Decreased, Hyperuricaemia

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.05 ?g/kg, qw
    Start date: 2012-06-05

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-05-15
    End date: 2012-06-04

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-14

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-28

Rebetol
    Dosage: 400 unk, unk
    Administration route: Oral
    Start date: 2012-06-26

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-07-16



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8 microgram per kilogram, unk
    Start date: 2012-06-27

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-06-26

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-27
    End date: 2012-07-09

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-10

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-06-08

Other drugs received by patient: Rikkunshi-TO; Sulpiride; Domperidone; L Cartin; Epadel; Lorfenamin



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram/kilogram/week
    Indication: Hepatitis C
    Start date: 2012-05-26

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26
    End date: 2012-05-28

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-05-29

Other drugs received by patient: Ferotym; Claritin Reditabs Tablets 10 MG; Livalo; Epadel S



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Weight Decreased, Visual Acuity Reduced, Weight Increased, Blood Calcium Decreased, Malaise, Fatigue, Skin Ulcer, Blood Count, Back Pain, Dyspnoea, Nausea, Anaemia, DRY Skin, Rash, Paraesthesia, Pollakiuria, Asthenia

Drug(s) suspected as cause:
Pegasys
    Dosage: 135 microgram, qw
    Start date: 2011-11-01
    End date: 2011-12-24

Pegasys
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-07-11

Rebetol
    Dosage: 800 mg, qd
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 600 mg, unk
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 1200, mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-11

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-08-08



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Tooth Fracture, Pruritus, Alcohol Abuse, Ejaculation Failure, Tooth Extraction, Psoriasis, Rash, Injection Site Erythema, Overdose, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-04-24

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-22



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Pruritus, Rash

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

PEG-Intron
    Dosage: 1.15 mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Other drugs received by patient: Urso 250; Loxoprofen



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Renal Impairment, Pruritus, Anaemia, Rash, Hyperuricaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.027mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-09

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-09
    End date: 2012-04-15

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-06-18

Rebetol
    Dosage: 200 mg, once
    Administration route: Oral
    Start date: 2012-06-11
    End date: 2012-06-17

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-16
    End date: 2012-06-10

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Other drugs received by patient: Voltaren; Voltaren-XR; Antebate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-04-10

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-29

PEG-Intron
    Dosage: 1.2mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-05
    End date: 2012-04-29

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-05
    End date: 2012-03-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-20
    End date: 2012-04-29

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-04-10

Telavic
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-29



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Drug Eruption, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3mcg/kg
    Indication: Hepatitis C
    Start date: 2012-06-21

Rebetol
    Administration route: Oral
    Start date: 2012-07-11

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-21

Rebetol
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-10

Telaprevir
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-06-25

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-21
    End date: 2012-06-25

Other drugs received by patient: Bisoprolol Fumarate; Diovan; Doxazosin Mesylate; Famotidine; Allopurinol



Possible Rebetol side effects in

Reported by a pharmacist from Japan on 2012-08-22

Patient:

Reactions: Renal Impairment, Cellulitis, Anaemia, Oedema DUE To Hepatic Disease, Rash, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-04-16

Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-04-17

PEG-Intron
    Dosage: 1.5mcg/kg
    Start date: 2012-04-24

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-03-28

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-04-10

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-28

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-03

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-29

Rebetol
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-04-10

Rebetol
    Administration route: Oral
    Start date: 2012-04-11

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-28

Telavic
    Administration route: Oral
    Start date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-04-16

Other drugs received by patient: Ferotym; Livalo; Mucodyne; Motilium; Epadel S; Claritin Reditabs; Vancomycin; Ferotym; Vancomycin



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Cheilitis, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-05-31

Telavic
    Administration route: Oral
    Start date: 2012-06-01

Other drugs received by patient: Urso 250



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Stomatitis, Anaemia, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 100 mg, once
    Administration route: Oral
    End date: 2012-03-06

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-21

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-07
    End date: 2012-02-13

Rebetol
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-06

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-28

Other drugs received by patient: Magmitt



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-15

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-06-03

Rebetol
    Administration route: Oral
    Start date: 2012-06-04

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15

Other drugs received by patient: Olopatadine HCL; Ferotym



Possible Rebetol side effects in

Reported by a pharmacist from Japan on 2012-08-22

Patient:

Reactions: Renal Disorder, Rash

Drug(s) suspected as cause:
PEG-Intron
    Start date: 2012-07-18

Rebetol
    Administration route: Oral
    Start date: 2012-07-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-18
    End date: 2012-07-20



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017